INS and Hyperinsulinemia: We also cover the underlying molecular mechanisms of IR and its relationship with dysfunctional insulin secretion from pancreatic beta cells and hepatic insulin clearance, resulting in a range of metabolic abnormalities from disproportionate hyperinsulinemia to glucose intolerance and type 2 diabetes (T2D).